Dai ichi Life Insurance Company Ltd Invests $396,000 in Henry Schein, Inc. (NASDAQ:HSIC)

Dai ichi Life Insurance Company Ltd bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC) during the third quarter, HoldingsChannel reports. The firm bought 5,433 shares of the company’s stock, valued at approximately $396,000.

Several other large investors have also recently bought and sold shares of the stock. The Manufacturers Life Insurance Company raised its stake in shares of Henry Schein by 8.1% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 540,089 shares of the company’s stock worth $39,372,000 after purchasing an additional 40,625 shares in the last quarter. Bank of Montreal Can grew its stake in shares of Henry Schein by 365.6% in the third quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock valued at $52,095,000 after buying an additional 558,689 shares in the last quarter. Daiwa Securities Group Inc. raised its position in Henry Schein by 11.4% during the third quarter. Daiwa Securities Group Inc. now owns 15,636 shares of the company’s stock worth $1,140,000 after acquiring an additional 1,596 shares in the last quarter. Cerity Partners LLC lifted its stake in Henry Schein by 12.3% in the third quarter. Cerity Partners LLC now owns 26,339 shares of the company’s stock valued at $1,920,000 after acquiring an additional 2,894 shares during the last quarter. Finally, Studio Investment Management LLC grew its position in shares of Henry Schein by 3.8% in the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after acquiring an additional 172 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 22.65 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on HSIC. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Robert W. Baird cut their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Evercore ISI raised their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Finally, UBS Group reduced their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $79.38.

Henry Schein Stock Up 0.5 %

HSIC stock opened at $77.66 on Friday. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The business has a 50-day simple moving average of $71.26 and a 200 day simple moving average of $69.84. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market cap of $9.68 billion, a PE ratio of 31.96, a price-to-earnings-growth ratio of 2.20 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.32 EPS. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.